Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy of Bevacizumab Monotherapy in Treatment of Metastatic Melanoma

This study has been completed.
Norwegian Cancer Society
Hoffmann-La Roche
Information provided by (Responsible Party):
Oddbjørn Straume, MD PhD, Haukeland University Hospital Identifier:
First received: August 30, 2005
Last updated: August 26, 2015
Last verified: August 2015